Gao, Catherine A. http://orcid.org/0000-0001-5576-3943
Howard, Frederick M. http://orcid.org/0000-0002-6039-1141
Markov, Nikolay S. http://orcid.org/0000-0002-3659-4387
Dyer, Emma C. http://orcid.org/0000-0002-5818-3589
Ramesh, Siddhi
Luo, Yuan http://orcid.org/0000-0003-0195-7456
Pearson, Alexander T.
Article History
Received: 1 January 2023
Accepted: 30 March 2023
First Online: 26 April 2023
Competing interests
: A.T.P. reports no competing interests for this work, and reports personal fees from Prelude Therapeutics Advisory Board, Elevar Advisory Board, AbbVie consulting, Ayala Advisory Board, and Privo Therapeutics, all outside of submitted work. The remaining authors declare no competing interests.